Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB)

Q: What does CUSIP 16385C104 represent in this 13F holders report?

CUSIP 16385C104 is the security identifier for CMMB - Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares used to aggregate holder disclosures.

Q: How many institutions held CMMB - Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares in Q3 2022?

13 institutional investors reported CMMB - Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares for Q3 2022. Use the holders table for investor-level position and value details.

CUSIP: 16385C104

Q3 2022 13F Holders as of 30 Sep 2022

Security type / class: Equity / Ordinary Shares / American Depositary Shares
Total 13F shares: 3,249,704
Total 13F value: $8,092,000
Share change: -35,604
SEC-reported price per share: $2.49
Number of holders: 13
Value change: -$130,379
Number of buys: 5
Number of sells: 6
Shares outstanding: 412,914,375

Security key

16385C104

Report period

Q3 2022

Institutions

Top holders

CMMB full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 Chemomab Therapeutics Ltd. SEC filings Chemomab Therapeutics Ltd. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 16385C104

Newer quarter: Q3 2025

Recent filing periods:

Q3 2025

Ownership snapshot

Top reported holders of CMMB - Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

ORBIMED ADVISORS LLC

Disclosed value leader

ORBIMED ADVISORS LLC

Comparable rows

0/15

Latest evidence

30 Jun 2022

13F Highest disclosed value: $16,616,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

ORBIMED ADVISORS LLC has the largest disclosed position value at $16.62M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ORBIMED ADVISORS LLC's linked filing trail.

Disclosed position value Top 5

ORBIMED ADVISORS LLC $16.62M

Novo Holdings A/S $4.32M

Cormorant Asset Management, LP $2.83M

Ikarian Capital, LLC $992K

MAI Capital Management $555K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
ORBIMED ADVISORS LLC	13F Company 13F	— mixed-class rows	$16,616,000 6,669,111 shares mixed-class rows	—	30 Jun 2022
Novo Holdings A/S	13F Company 13F	— denominator unverified	$4,321,000 2,497,791 shares	—	30 Jun 2022
Cormorant Asset Management, LP	13F Company 13F	— mixed-class rows	$2,831,000 1,308,406 shares mixed-class rows	—	30 Jun 2022
Ikarian Capital, LLC	13F Company 13F	— denominator unverified	$992,000 268,104 shares	—	30 Jun 2022
MAI Capital Management	13F Company 13F	— denominator unverified	$555,000 320,860 shares	—	30 Jun 2022
RENAISSANCE TECHNOLOGIES LLC	13F Company 13F	— denominator unverified	$427,000 246,711 shares	—	30 Jun 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

3,249,704

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders

Q3 2022 holders

Holder diff

Investor	Q2 2022 Shares	Q3 2022 Shares	Share Diff	Share Chg %	Q2 2022 value	Q3 2022 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend